Loading clinical trials...
Loading clinical trials...
Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab (AMG 145) in Japan
Conditions
Interventions
No intervention
Locations
138
Japan
Research Site
Ichinomiya, Aichi-ken, Japan
Research Site
Ichinomiya, Aichi-ken, Japan
Research Site
Inuyama, Aichi-ken, Japan
Research Site
Kasugai, Aichi-ken, Japan
Research Site
Komaki, Aichi-ken, Japan
Research Site
Nagoya, Aichi-ken, Japan
Start Date
June 24, 2016
Primary Completion Date
October 31, 2022
Completion Date
March 30, 2023
Last Updated
November 21, 2024
NCT07058077
NCT06555120
NCT06287177
NCT00353782
NCT06556745
NCT06314919
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions